05/06/2024
The Consultation Papers, Circular and Feedback Statement primarily focus on the removal of non-recourse arrangements for pure captives and reinsurers, transfers of protected cells and liquidation of protected cells.
04/30/2024
In scenarios where these vehicles are within scope of the CTA, the Maples Group provides a dedicated range of CTA services, which will significantly alleviate the regulatory and compliance burden for clients and US counsel from this legislation.
04/29/2024
These changes have been incorporated into the updated Handbook and, where applicable, corresponding rules and guidance have also been amended.